Insider Transactions in Q3 2024 at 89bio, Inc. (ETNB)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
5,352
-2.42%
|
$42,816
$8.46 P/Share
|
|
Sep 09
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,212
-3.04%
|
$25,696
$8.46 P/Share
|
|
Sep 09
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,352
-3.4%
|
$42,816
$8.46 P/Share
|
|
Aug 17
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.66%
|
$8,368
$8.04 P/Share
|
|
Aug 17
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.47%
|
$8,368
$8.04 P/Share
|
|
Aug 17
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-0.73%
|
$6,216
$8.04 P/Share
|
|
Aug 17
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,601
-1.0%
|
$36,808
$8.04 P/Share
|
|
Aug 05
2024
|
Francis Willard Sarena Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|